Ultrasensitive Next-Generation Sequencing-Based Measurable Residual Disease Assessment in Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia after Frontline Therapy: Correlation with Flow Cytometry and Impact on Clinical Outcomes
暂无分享,去创建一个
M. Konopleva | H. Kantarjian | K. Patel | F. Ravandi | E. Jabbour | S. Kornblau | N. Jain | N. Short | J. Jorgensen | Sa A. Wang | J. Matthews | P. Kebriaei | M. Yilmaz | G. Issa | Munazza Noor | R. Garris